NEAT-A: Accelerated sequential epirubicin followed by CMF using pegfilgrastim is a feasible regimen for delivering dose dense chemotherapy in early breast cancer

@inproceedings{Rea2007NEATAAS,
  title={NEAT-A: Accelerated sequential epirubicin followed by CMF using pegfilgrastim is a feasible regimen for delivering dose dense chemotherapy in early breast cancer},
  author={Daniel Rea and Sarah Bowden and Lilyana Gross and Christopher J. Poole and Louise Hiller and Rajiv Agrawal and Karen McAdam and Helena Margaret Earl and Sadia Anwar},
  year={2007}
}

Topics from this paper.

Similar Papers

Loading similar papers…